Explore 3 Stock Ideas & Industry Insights Download Free Report

Medigus Ltd ADR

Company price
None USD 0.00(0%)
Last update at 2024-07-24T15:01:29.903699Z
Market Cap
4.47M

Momentum Score

…

Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, and visualization solutions; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
1.50
Low
6.91
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
110.28M
Revenue Per Share
67.31
Gross Profit TTM
4.80M
Debt / Equity
0.42
ROE
-30.72%
Net Debt
0.43M
ROCE
-39.81%
Diluted EPS TTM
-8.70

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -10.10M 4.15M -6.84M -14.18M -6.58M
Minority interest 0.39M 2.75M 3.23M 1.42M 1.42M
Net income -10.21M 4.05M -6.85M -14.18M -6.60M
Selling general administrative 14.17M 9.96M 5.49M 13.18M 3.34M
Selling and marketing expenses 4.01M 1.99M 0.47M 0.33M 1.35M
Gross profit 14.45M 4.80M -0.50M -0.18M -0.17M
Reconciled depreciation 3.24M 0.32M 0.17M 0.07M 0.04M
Ebit -13.78M -8.20M -7.38M -14.42M -6.82M
Ebitda -11.99M -22.23M -7.89M -14.46M -6.78M
Depreciation and amortization 1.80M -14.03M -0.50M -0.04M 0.04M
Operating income -13.78M -8.20M -7.38M -14.42M -6.67M
Other operating expenses 100.44M 18.31M 8.00M 14.57M 7.11M
Interest expense -4.08M 29.44M 3.74M 0.35M 0.00M
Tax provision 0.11M 0.10M 0.01M -0.00M 0.02M
Interest income - - - 0.14M 0.15M
Net interest income -2.31M -0.35M 0.20M 0.10M -0.05M
Extraordinary items - - - - 0.00M
Non recurring - - - - 0.00M
Other items - - - - 0.00M
Income tax expense 0.11M 0.10M 0.01M -0.00M 0.02M
Total revenue 91.86M 10.12M 0.53M 0.27M 0.44M
Total operating expenses 23.03M 13.00M 6.96M 14.11M 6.50M
Cost of revenue 77.41M 5.32M 1.03M 0.46M 0.61M
Total other income expense net 3.69M 12.35M 0.54M 0.24M 0.15M
Discontinued operations - - - - 0.00M
Net income from continuing ops -10.21M 4.05M -6.85M -14.18M -6.60M
Net income applicable to common shares - 6.79M -4.33M -14.18M -6.60M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 63.90M 97.65M 59.73M 32.34M 13.33M
Intangible assets 18.79M 21.79M 7.39M - -
Other current assets 1.11M 0.18M 0.27M 0.38M 0.19M
Total liab 31.46M 42.96M 8.30M 6.14M 5.20M
Total stockholder equity 23.58M 39.14M 49.19M 22.96M 6.71M
Deferred long term liab - - 0.84M - -
Other current liab 3.04M 10.41M 4.90M 3.25M 2.67M
Common stock - - - 93.02M 22.80M
Capital stock 0.00M 0.00M 0.00M 93.02M 22.80M
Retained earnings -101.61M -85.59M -74.19M -80.98M -76.66M
Other liab - - 0.97M 2.58M 1.80M
Good will 8.55M 9.07M 0.93M - -
Other assets - - 0.84M 1.15M 4.09M
Cash 9.36M 20.07M 24.02M 22.36M 7.04M
Total current liabilities 29.27M 37.63M 6.64M 3.51M 3.37M
Current deferred revenue 3.90M 0.05M 0.11M 0.07M 0.50M
Net debt 0.43M -9.93M -22.41M -22.26M -6.88M
Short term debt 9.08M 6.74M 0.93M 0.06M 0.12M
Short long term debt 8.98M 6.61M 0.93M - -
Short long term debt total 9.79M 10.13M 1.62M 0.11M 0.15M
Other stockholder equity 113.08M 111.52M 110.76M 0.20M 48.07M
Property plant equipment - - 0.08M 0.37M 0.27M
Total current assets 31.67M 52.26M 31.65M 24.05M 8.28M
Long term investments 3.77M 13.13M 18.84M 6.19M 4.76M
Net tangible assets - - 40.87M 22.39M 6.69M
Short term investments 3.18M 4.99M 3.31M - 0.00M
Net receivables 15.64M 25.23M 1.69M 0.26M 0.07M
Long term debt 0.23M 2.88M 0.69M - -
Inventory 2.39M 1.79M 1.23M 0.24M 0.90M
Accounts payable 13.25M 20.42M 0.70M 0.14M 0.07M
Accumulated other comprehensive income 12.11M 13.21M 12.62M 10.72M 12.49M
Non currrent assets other - - 0.84M 1.15M 5.05M
Non current assets total 32.23M 45.39M 28.08M 8.29M 5.05M
Capital lease obligations 0.57M 0.64M 0.00M 0.11M 0.15M
Long term debt total - - - - 0.03M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -4.48M -2.82M -1.82M -4.12M 3.49M
Change to liabilities - -0.04M 0.26M 1.84M 0.17M
Total cashflows from investing activities - -12.45M -1.60M -4.12M 3.49M
Net borrowings - 0.43M -0.05M -0.05M -0.05M
Total cash from financing activities 5.41M 19.15M 22.95M 3.16M 8.63M
Change to operating activities - 1.18M -0.01M 0.20M 0.12M
Net income -10.10M 4.15M -6.84M -14.18M -6.58M
Change in cash -3.96M 1.66M 15.33M -3.59M 7.80M
Begin period cash flow 24.02M 22.36M 7.04M 10.62M 2.83M
End period cash flow 20.07M 24.02M 22.36M 7.04M 10.62M
Total cash from operating activities -5.66M -5.25M -6.14M -2.69M -4.22M
Issuance of capital stock 12.57M 18.72M 22.99M 0.00M 8.63M
Depreciation 3.24M 0.32M 0.17M 0.07M 0.04M
Other cashflows from investing activities - -1.47M -1.47M -4.06M 3.50M
Dividends paid -4.19M - -0.12M - 0.00M
Change to inventory -0.56M -0.55M -0.47M -0.82M 0.02M
Change to account receivables -7.84M -0.24M -0.07M 0.00M -0.01M
Sale purchase of stock - - -22.95M - 8.63M
Other cashflows from financing activities 1.75M 1.92M 0.12M 3.20M 3.49M
Change to netincome - -12.48M -1.68M 10.19M 2.03M
Capital expenditures 0.07M 0.14M 0.32M 0.06M 0.01M
Change in working capital -1.12M 0.12M -0.28M 1.22M 0.31M
Stock based compensation 0.79M 2.36M 1.39M 0.26M 0.16M
Other non cash items 1.15M 0.58M 0.54M 10.03M -0.04M
Free cash flow -5.73M -5.39M -6.47M -2.76M -4.23M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ABT
Abbott Laboratories
-0.03
0.03%
109.93 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC
-3.04
2.90%
101.80 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation
-9.21
2.75%
325.87 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG
-2.15
4.12%
49.85 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Medigus Ltd ADR

Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, and visualization solutions; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

10 Hanechoshet, Tel Aviv, Israel, 6971072

972 73 370 4691

77

Name Title Year Born
Mr. Liron Carmel Chief Exec. Officer 1985
Ms. Tali Dinar Chief Financial Officer 1971
Dr. Yaron Silberman Chief Exec. Officer of ScoutCam Ltd. 1970
Ilan Oren Exec. Officer NA
Mr. Liron Carmel Chief Executive Officer 1985
Dr. Yaron Silberman Chief Executive Officer of ScoutCam Ltd. 1970
Ilan Oren Executive Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…